Robb Gary Charles, Chief Business Officer of Corcept Therapeutics Inc. ($CORT), made three open market sales of company stock over the past year, totaling about $564 thousand. His most recent sale occurred on August 22, 2025. These transactions rank 6,187th among 11,678 insiders in our database, below the average sale amount of $8.6 million across about 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 121 | $35.97 | 102,645.0000 | 119,981,000 | 0.12% | 0.00% |
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 499 | $0.00 | 102,766.0000 | 119,981,000 | 0.49% | 0.00% |
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 499 | $35.97 | 102,267.0000 | 119,981,000 | 0.49% | 0.00% |
| Feb. 27, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 119,981,000 | 9999.99% | 0.12% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 80284 | $83.59 | 101,768.0000 | 119,981,000 | 44.10% | 0.07% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 145000 | $0.00 | 0.0000 | 119,981,000 | 100.00% | 0.12% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 145000 | $3.88 | 182,052.0000 | 119,981,000 | 391.34% | 0.12% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 224 | $79.78 | 36,976.0000 | 119,981,000 | 0.61% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 224 | $0.00 | 37,200.0000 | 119,981,000 | 0.61% | 0.00% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 148 | $79.78 | 37,052.0000 | 119,981,000 | 0.40% | 0.00% |
| Sept. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 256 | $71.38 | 36,752.0000 | 113,480,000 | 0.69% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 251 | $0.00 | 37,008.0000 | 113,480,000 | 0.68% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 251 | $71.38 | 36,757.0000 | 113,480,000 | 0.69% | 0.00% |
| Aug. 22, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 2674 | $71.17 | 36,506.0000 | 113,480,000 | 6.82% | 0.00% |
| Aug. 22, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 5000 | $3.88 | 41,506.0000 | 113,480,000 | 13.70% | 0.00% |
| Aug. 22, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 2326 | $71.27 | 39,180.0000 | 113,480,000 | 5.60% | 0.00% |
| Aug. 22, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 5000 | $0.00 | 145,000.0000 | 113,480,000 | 3.33% | 0.00% |
| June 16, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 3185 | $70.77 | 36,506.0000 | 113,480,000 | 8.02% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 997 | $0.00 | 40,342.0000 | 113,480,000 | 2.53% | 0.00% |
| June 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 651 | $71.68 | 39,691.0000 | 113,480,000 | 1.61% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 997 | $71.68 | 39,345.0000 | 113,480,000 | 2.60% | 0.00% |
| May 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 360 | $0.00 | 26,777.0000 | 113,480,000 | 1.36% | 0.00% |
| May 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 1380 | $0.00 | 26,777.0000 | 113,480,000 | 4.90% | 0.00% |
| May 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 2279 | $75.85 | 28,157.0000 | 113,480,000 | 7.49% | 0.00% |
| May 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 360 | $0.00 | 26,777.0000 | 113,480,000 | 1.36% | 0.00% |
| Jan. 27, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 313 | $0.00 | 30,076.0000 | 113,480,000 | 1.05% | 0.00% |
| Jan. 27, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 313 | $0.00 | 30,076.0000 | 113,480,000 | 1.05% | 0.00% |
| March 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 233 | $0.00 | 29,763.0000 | 113,480,000 | 0.79% | 0.00% |
| March 20, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 233 | $0.00 | 29,763.0000 | 113,480,000 | 0.79% | 0.00% |
| March 12, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 1000 | $0.00 | 29,530.0000 | 113,480,000 | 3.51% | 0.00% |
| March 12, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 1000 | $0.00 | 29,530.0000 | 113,480,000 | 3.51% | 0.00% |
| March 12, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 4625 | $0.00 | 29,530.0000 | 113,480,000 | 13.54% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 292 | $59.07 | 42,528.0000 | 113,480,000 | 0.69% | 0.00% |
| Feb. 28, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Stock option (right to buy) | 140000 | $0.00 | 140,000.0000 | 113,480,000 | 9999.99% | 0.12% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 250 | $60.58 | 42,236.0000 | 113,480,000 | 0.59% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 292 | $0.00 | 42,820.0000 | 113,480,000 | 0.69% | 0.00% |
| Jan. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 3037 | $3.29 | 42,486.0000 | 113,480,000 | 7.70% | 0.00% |
| Jan. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 3037 | $0.00 | 0.0000 | 113,480,000 | 100.00% | 0.00% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 11000 | $3.29 | 50,449.0000 | 113,480,000 | 27.88% | 0.01% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 11000 | $50.50 | 39,449.0000 | 113,480,000 | 21.80% | 0.01% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 11000 | $0.00 | 3,037.0000 | 113,480,000 | 78.36% | 0.01% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 324 | $57.68 | 38,869.0000 | 113,723,000 | 0.83% | 0.00% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 290 | $0.00 | 39,449.0000 | 113,723,000 | 0.74% | 0.00% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 290 | $59.21 | 39,159.0000 | 113,723,000 | 0.75% | 0.00% |
| Nov. 22, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 2609 | $56.20 | 39,493.0000 | 113,723,000 | 6.20% | 0.00% |
| Nov. 22, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 300 | $0.00 | 39,193.0000 | 113,723,000 | 0.76% | 0.00% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 11000 | $0.00 | 14,037.0000 | 113,723,000 | 43.93% | 0.01% |
| Sept. 27, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 415 | $0.00 | 32,437.0000 | 111,742,000 | 1.30% | 0.00% |
| Sept. 27, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 415 | $0.00 | 32,437.0000 | 111,742,000 | 1.30% | 0.00% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 11000 | $3.29 | 43,437.0000 | 113,723,000 | 33.91% | 0.01% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 11000 | $46.28 | 32,437.0000 | 113,723,000 | 25.32% | 0.01% |
| Sept. 18, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 870 | $0.00 | 41,272.0000 | 111,742,000 | 2.06% | 0.00% |
| Sept. 17, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 300 | $0.00 | 42,142.0000 | 111,742,000 | 0.71% | 0.00% |
| Sept. 18, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | J | Common Stock | 7250 | $0.00 | 41,272.0000 | 111,742,000 | 14.94% | 0.01% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 503 | $34.26 | 49,189.0000 | 111,742,000 | 1.03% | 0.00% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 503 | $0.00 | 49,692.0000 | 111,742,000 | 1.02% | 0.00% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 254 | $35.30 | 48,686.0000 | 111,742,000 | 0.52% | 0.00% |
| Aug. 26, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 3101 | $35.71 | 48,940.0000 | 111,742,000 | 5.96% | 0.00% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 11000 | $3.29 | 63,041.0000 | 111,742,000 | 21.14% | 0.01% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 11000 | $32.49 | 52,041.0000 | 111,742,000 | 17.45% | 0.01% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 11000 | $0.00 | 25,037.0000 | 111,742,000 | 30.52% | 0.01% |
| June 24, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 550 | $0.00 | 35,541.0000 | 111,742,000 | 1.57% | 0.00% |
| June 24, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 550 | $0.00 | 33,541.0000 | 111,742,000 | 1.67% | 0.00% |
| June 24, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 2650 | $0.00 | 35,541.0000 | 111,742,000 | 6.94% | 0.00% |
| June 24, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | J | Common Stock | 1000 | $0.00 | 32,991.0000 | 111,742,000 | 2.94% | 0.00% |
| June 24, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 550 | $0.00 | 35,541.0000 | 111,742,000 | 1.57% | 0.00% |
| June 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 14000 | $3.29 | 62,215.0000 | 111,742,000 | 29.04% | 0.01% |
| June 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 8174 | $32.87 | 54,041.0000 | 111,742,000 | 13.14% | 0.01% |
| June 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 14000 | $0.00 | 36,037.0000 | 111,742,000 | 27.98% | 0.01% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 724 | $30.17 | 44,579.0000 | 111,742,000 | 1.60% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 1818 | $0.00 | 48,215.0000 | 111,742,000 | 3.92% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 1818 | $31.30 | 46,397.0000 | 111,742,000 | 4.08% | 0.00% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 11000 | $0.00 | 50,037.0000 | 111,742,000 | 18.02% | 0.01% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 11000 | $3.29 | 56,303.0000 | 111,742,000 | 24.28% | 0.01% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 11000 | $30.39 | 45,303.0000 | 111,742,000 | 19.54% | 0.01% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 697 | $0.00 | 45,303.0000 | 111,742,000 | 1.56% | 0.00% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 656 | $24.06 | 43,909.0000 | 111,742,000 | 1.47% | 0.00% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 697 | $24.06 | 44,606.0000 | 111,742,000 | 1.59% | 0.00% |
| Feb. 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 111,742,000 | 9999.99% | 0.18% |
| Feb. 22, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 1175 | $0.00 | 44,565.0000 | 115,966,000 | 2.57% | 0.00% |
| Dec. 15, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 45,740.0000 | 115,966,000 | 1.61% | 0.00% |
| Dec. 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | J | Common Stock | 1000 | $0.00 | 46,490.0000 | 115,966,000 | 2.11% | 0.00% |
| Dec. 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 639 | $0.00 | 30,090.0000 | 115,966,000 | 2.17% | 0.00% |
| Dec. 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 639 | $0.00 | 30,090.0000 | 115,966,000 | 2.17% | 0.00% |
| Dec. 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 639 | $0.00 | 30,090.0000 | 115,966,000 | 2.17% | 0.00% |
| Dec. 4, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 8788 | $26.26 | 53,166.0000 | 115,966,000 | 14.18% | 0.01% |
| Dec. 4, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 15000 | $3.29 | 61,954.0000 | 115,966,000 | 31.95% | 0.01% |
| Dec. 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 1381 | $26.27 | 51,785.0000 | 115,966,000 | 2.60% | 0.00% |
| Dec. 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 6212 | $27.01 | 45,573.0000 | 115,966,000 | 12.00% | 0.01% |
| Dec. 4, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 15000 | $0.00 | 61,037.0000 | 115,966,000 | 19.73% | 0.01% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 638 | $25.97 | 46,316.0000 | 115,966,000 | 1.40% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 638 | $0.00 | 46,954.0000 | 115,966,000 | 1.38% | 0.00% |
| Sept. 19, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 5000 | $32.74 | 46,179.0000 | 115,966,000 | 9.77% | 0.00% |
| Sept. 14, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 13963 | $0.00 | 25,000.0000 | 115,966,000 | 126.51% | 0.01% |
| Sept. 14, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 7996 | $33.80 | 51,179.0000 | 115,966,000 | 13.51% | 0.01% |
| Sept. 14, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 13963 | $3.29 | 59,175.0000 | 115,966,000 | 30.88% | 0.01% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 500 | $33.10 | 44,712.0000 | 115,966,000 | 1.13% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 500 | $0.00 | 45,212.0000 | 115,966,000 | 1.12% | 0.00% |
| June 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 600 | $0.00 | 44,212.0000 | 115,966,000 | 1.34% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 30,790.0000 | 115,966,000 | 2.30% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 30,065.0000 | 115,966,000 | 2.35% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 29,340.0000 | 115,966,000 | 2.41% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 650 | $0.00 | 28,690.0000 | 115,966,000 | 2.22% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 28,690.0000 | 115,966,000 | 2.59% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 28,690.0000 | 115,966,000 | 2.59% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 28,690.0000 | 115,966,000 | 2.59% | 0.00% |
| June 8, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 725 | $0.00 | 31,515.0000 | 115,966,000 | 2.25% | 0.00% |
| June 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 2091 | $22.97 | 44,096.0000 | 115,966,000 | 4.98% | 0.00% |
| June 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 2091 | $0.00 | 46,187.0000 | 115,966,000 | 4.74% | 0.00% |
| May 9, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 30000 | $23.87 | 56,005.0000 | 115,966,000 | 34.88% | 0.03% |
| May 10, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | S | Common Stock | 14000 | $24.07 | 42,005.0000 | 115,966,000 | 25.00% | 0.01% |
| May 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 45000 | $1.92 | 86,591.0000 | 115,966,000 | 108.20% | 0.04% |
| May 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Common Stock | 60000 | $3.29 | 146,591.0000 | 115,966,000 | 69.29% | 0.05% |
| May 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | F | Common Stock | 60586 | $24.07 | 86,005.0000 | 115,966,000 | 41.33% | 0.05% |
| May 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 45000 | $0.00 | 0.0000 | 115,966,000 | 100.00% | 0.04% |
| May 5, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | M | Stock option (right to buy) | 60000 | $0.00 | 38,963.0000 | 115,966,000 | 60.63% | 0.05% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 1600 | $0.00 | 41,591.0000 | 115,966,000 | 4.00% | 0.00% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Common Stock | 1600 | $19.86 | 39,991.0000 | 115,966,000 | 4.17% | 0.00% |
| Feb. 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 115,966,000 | 9999.99% | 0.17% |
| Dec. 15, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 772 | $0.00 | 23,719.0000 | 0 | 3.36% | 0.00% |
| Nov. 21, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 560 | $0.00 | 23,719.0000 | 0 | 2.31% | 0.00% |
| Feb. 23, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 1950 | $0.00 | 24,279.0000 | 0 | 7.43% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 22,947.0000 | 0 | 3.38% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 26,229.0000 | 0 | 2.78% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 22,947.0000 | 0 | 3.38% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 26,979.0000 | 0 | 2.70% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 22,947.0000 | 0 | 3.38% | 0.00% |
| Feb. 8, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 750 | $0.00 | 27,729.0000 | 0 | 2.63% | 0.00% |
| Dec. 15, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 772 | $0.00 | 23,719.0000 | 0 | 3.36% | 0.00% |
| Dec. 15, 2022 | CORCEPT THERAPEUTICS INC | $CORT | Robb Gary Charles | Chief Business Officer | G | Common Stock | 772 | $0.00 | 23,719.0000 | 0 | 3.36% | 0.00% |